Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis — Stella

Recruiting

Back to Breast Cancer trials

Trial locations(3 sites)

United States

H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida

Hawaii Radiology Associates, LTD (East Hawaii Women's Imaging Center), Hilo, Hawaii

The Queen's Medical Center, Honolulu, Hawaii

Key details

Sponsor

University of Hawaii

Collaborators

H. Lee Moffitt Cancer Center and Research Institute, Queen's Medical Center

Enrollment target

~600 participants

Started

August 2022

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 85 Years

Sex

Female only

Last updated February 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov